Skip to main content
Sachiko Ozawa on Muck Rack

Sachiko Ozawa

Japan
As seen in: CNN, MSN Canada, Applied Health Economics and Health Policy, PLOS ONE, BMJ Open, Health Policy and Planning, Health Affairs, Healio, Devex, GHSP Journal and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sachiko

Contact Sachiko, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Reduction of biologic pricing following biosimilar introduction: Analysis across 57 countries and regions, 2012-19

|
By Hui-Han Chen, Tatenda T. Yemeke, Sachiko Ozawa
| PLOS ONE
Methods To understand the impact of introducing biosimilars on global biologic prices, we conducted a retrospective interrupted time series (ITS) analysis assessing yearly prices of biologics from January 2012 to December 2019. We utilized the global sales data of biologics in the IQVIA MIDAS® data, which were obtained under license from IQVIA and reflect estimates of marketplace activity.
Open in Who Shared Issue with article?

Impact of the COVID-19 pandemic on the quality of medical products in Zimbabwe: a qualitative study based on key informant interviews with health system stakeholders

|
By Tatenda T. Yemeke, Rashida A Ferrand, Sachiko Ozawa, Farouk A Umaru
| BMJ Open Verified
Increased risks to quality COVID-19-related supply chain disruptions led to increased risks to the quality of medical products. For example, participants stated that in response to shortages and supply bottlenecks associated with COVID-19, as well as increased demand for medical products used for COVID-19 management, there was a significant increase in medical products procured under special provisions that waived registration requirements.
Open in Who Shared Issue with article?

Online search for oral chemotherapy drug will likely lead your patient to ‘rogue’ pharmacy

|
By Drew Amorosi, Mindy Valcarcel, Sachiko Ozawa
| HemOnc Today Verified
Source/Disclosures We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. As patients with cancer look to the internet for deals on costly medications, results of a study showed most online pharmacies that claimed to sell the oral chemotherapy drug imatinib engaged in illegal, unsafe or misleading activities.
Open in Who Shared Issue with article?
See all 16 licensed articles (18 Total)